GLIOBLASTOMAS

Clinical trials for GLIOBLASTOMAS explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMAS trials appear

Sign up with your email to follow new studies for GLIOBLASTOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for recurrent glioblastoma: experimental drug LMP744 enters human trials

Disease control Recruiting now

This study tests a new drug called LMP744 in people whose glioblastoma has come back after standard treatment. The drug is designed to kill cancer cells by blocking a key growth signal and interfering with DNA repair. Participants will receive the drug through a vein for 5 days e…

Matched conditions: GLIOBLASTOMAS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

GLIOBLASTOMAS

Get alerted when new GLIOBLASTOMAS trials appear

New hope for recurrent glioblastoma: experimental drug LMP744 enters human trials